Holen Sie sich die Stockscreener-App
0.8062
2.93%
-0.0243
Schlusskurs vom Vortag:
$0.8305
Offen:
$0.82
24-Stunden-Volumen:
102.98K
Relative Volume:
0.11
Marktkapitalisierung:
$15.78M
Einnahmen:
$1.89M
Nettoeinkommen (Verlust:
$-17.92M
KGV:
-0.1205
EPS:
-6.69
Netto-Cashflow:
$-15.62M
1W Leistung:
-13.21%
1M Leistung:
+2.27%
6M Leistung:
-48.32%
1J Leistung:
-62.68%
1-Tages-Spanne:
$0.8041
$0.8205
1-Wochen-Bereich:
$0.8041
$0.925
52-Wochen-Spanne:
$0.633
$2.31
Longeveron Inc Stock (LGVN) Company Profile
Firmenname
Longeveron Inc
Sektor
Branche
Telefon
305-302-7158
Adresse
1951 NW 7TH AVENUE, MIAMI
Vergleichen Sie LGVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.8062 | 17.49M | 1.89M | -17.92M | -15.62M | -6.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.25 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.15 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.04 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.63 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.81 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
Longeveron Inc Aktie (LGVN) Neueste Nachrichten
Why analysts upgrade Longeveron Inc. stockRisk Management & Real-Time Market Trend Scan - newser.com
Is Longeveron Inc. stock in correction or buying zoneJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Earnings To Watch: Longeveron Inc (LGVN) Reports Q3 2025 Result - GuruFocus
Is it too late to sell Longeveron Inc.July 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
Will Longeveron Inc. stock remain a Wall Street favoriteWeekly Stock Summary & Consistent Income Trade Recommendations - newser.com
What dividend safety score for Longeveron Inc. stockJuly 2025 News Drivers & AI Forecast Swing Trade Picks - newser.com
Visualizing Longeveron Inc. stock with heatmapsQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
What data driven models say about Longeveron Inc.’s futureWeekly Investment Summary & Low Volatility Stock Recommendations - newser.com
Can you recover from losses in Longeveron Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
How to recover losses in Longeveron Inc. stockCEO Change & Long-Term Capital Growth Strategies - newser.com
What analysts say about Longeveron Inc stockBullish Engulfing Patterns & Free Dashboard to Track Market Momentum - earlytimes.in
Will Longeveron Inc. stock continue dividend increasesWeekly Trade Analysis & Low Drawdown Momentum Ideas - newser.com
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 - The Manila Times
Should you wait for a breakout in Longeveron Inc.Market Rally & Smart Investment Allocation Tips - newser.com
Will Longeveron Inc. stock deliver strong dividend growth2025 Breakouts & Breakdowns & Consistent Growth Equity Picks - Fundação Cultural do Pará
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR’s BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect - The Manila Times
Longeveron (NASDAQ: LGVN) completes ELPIS II enrollment; HLHS trial top-line Q3 2026 - Stock Titan
Finanzdaten der Longeveron Inc-Aktie (LGVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Longeveron Inc-Aktie (LGVN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Soffer Rock | Director |
May 29 '25 |
Sale |
1.30 |
10,000 |
13,000 |
220,034 |
1.71%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):